Eric Vivier: Association of COVID-19 Inflammation with Activation of the C5a-C5aR1 Axis
On-Demand
            
            Eric Vivier provides a longitudinal analysis of immune responses, including immune cell phenotyping and assessments of the soluble factors present in the blood and broncho-alveolar…
        
    
        Salim S. Abdool Karim: COVID-19 in South Africa
On-Demand
            
            Since the first case of COVID-19 on 5 March 2020 in South Africa, the epidemic grew exponentially with a doubling time of 2 days for…
        
    
        Donna Farber: Respiratory Immunity and COVID-19
On-Demand
            
            Donna Farber discusses the development of lung-localized immune responses and the role of tissue resident memory T cells in protective immunity to respiratory viruses, in…
        
    
        Lisa Ng: Understanding Infection and Immunity of SARS-CoV-2: from diagnostics to therapies for COVID-19
On-Demand
            
            SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is the causative agent of the ongoing Coronavirus Disease 2019 (COVID-19) pandemic. Alongside investigations into the virology of…
        
    
        Sharon Lewin and Katherine Kedzierska: COVID-19 in Australia: Being prepared and understanding the role of cellular immune responses
On-Demand
            
            What role do cellular immune responses play in squashing the curve of COVID-19 infections? Sharon Lewin and Katherine Kedzierska show how immunity to SARS-CoV2 has demonstrated the…
        
    
        Mihai Netea: Trained immunity and BCG vaccination: a tool against COVID-19?
On-Demand
            
            What do we know about the adaptive characteristics of innate immune responses? Does BCG induce long-term changes in innate immune cells? What are the non-specific…
        
    
        Andreas Radbruch: Adaptive Immunity in COVID-19
On-Demand
            
            Adaptive Immunity: Memory, Protection and Immunopathology in COVID-19: What do we know about the adaptive immune reaction to Sars-CoV-2? Why do humans react so heterogeneously…
        
    
        Rachel Humphrey: What cancer immunologists are doing about COVID-19
On-Demand
            
            What are physicians and scientists seeing in their COVID-19-infected patients and in their own personal scientific explorations? What are the ongoing hypotheses that drive the…
        
    
        Eleanor Fish: Global outbreaks – Interferons as 1st responders
On-Demand
            
            Can antivirals that target the host and not the virus improve outcomes for COVID-19 patients? Professor Eleanor Fish from the University of Toronto showed that…
        
    
        Giuseppe Ippolito: The Global Scientific Response to COVID-19
On-Demand
            
            Giuseppe Ippolito, Scientific Director at the National Institute for Infectious Diseases in Rome, Italy, shares his opinion on why policy responses to the coronavirus pandemic…
        
    
        Rino Rappuoli: COVID-19 Vaccines
On-Demand
            
            How long will it really take to develop a vaccine for COVID-19, and how is science speeding up the process? Rino Rappuoli, Chief Scientist and…
        
    
        
 
                     
                     
                     
                     
                     
                     
                     
                     
                    